Kevin Harrington

NHS Foundation Trust - Royal Marsden Hospital

Sutton

Surrey

London

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS

164

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Establishment of CORONET: COVID-19 Risk in Oncology Evaluation Tool to Identify Cancer Patients at Low Versus High Risk of Severe Complications of COVID-19 Infection Upon Presentation to Hospital

Number of pages: 51 Posted: 28 Jul 2021
The Christie NHS Foundation Trust, The University of Manchester, University of Manchester - Digital Experimental Cancer Medicine, affiliation not provided to SSRN, The University of Manchester, The University of Manchester, The University of Manchester, affiliation not provided to SSRN, ITG, Inc. - ITG London, affiliation not provided to SSRN, Manchester Academic Health Sciences Centre - The Christie NHS Foundation Trust, University of Dundee, affiliation not provided to SSRN, affiliation not provided to SSRN, Manchester Academic Health Sciences Centre - The Christie NHS Foundation Trust, Hospital General Universitario Gregorio Marañón, affiliation not provided to SSRN, University of Southampton - University Hospital Southampton NHS Foundation Trust, Fundeni Clinical Institute, Lahey Hospital and Medical Center - Division of Cardiovascular Medicine, affiliation not provided to SSRN, University Hospitals Plymouth NHS Trust, University of Manchester - Digital Experimental Cancer Medicine, University of Manchester - Digital Experimental Cancer Medicine, Lahey Hospital and Medical Center - Division of Cardiovascular Medicine, affiliation not provided to SSRN, The Christie NHS Foundation Trust, affiliation not provided to SSRN, affiliation not provided to SSRN, NHS Foundation Trust - Royal Marsden Hospital, Ninewells Hospital and Medical School, affiliation not provided to SSRN, University of Manchester - Research IT, affiliation not provided to SSRN, affiliation not provided to SSRN, University College London Hospital, Government of the United Kingdom - Oncology Department, Clatterbridge Cancer Centre, University College London - UCL Cancer Institute, Sheffield Teaching Hospitals NHS Foundation Trust, University of Southampton - Cancer Sciences Academic Unit, University of Lausanne - Lausanne University Hospital, Lahey Hospital and Medical Center, affiliation not provided to SSRN, Lahey Hospital and Medical Center - Department of Internal Medicine, affiliation not provided to SSRN, Centre Hospitalier Universitaire Vaudois (CHUV), Lahey Hospital and Medical Center, Bristol Haematology and Oncology Centre, affiliation not provided to SSRN, PSL Research University - Institut Curie, Royal Cornwall Hospital - Sunrise Centre, I.M. Sechenov First Moscow State Medical University, affiliation not provided to SSRN, affiliation not provided to SSRN, National Institute for Health Research (NIHR), Government of the United Kingdom - Oncology Department, University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Hospital Universitario La Paz - Department of Medical Oncology, The Christie NHS Foundation Trust, Government of the United Kingdom - Weston Park Cancer Centre, Government of the United Kingdom - Weston Park Cancer Centre, affiliation not provided to SSRN, affiliation not provided to SSRN, The Christie NHS Foundation Trust, Independent, The University of Manchester, The University of Manchester and The Christie NHS Foundation Trust
Downloads 106 (524,314)

Abstract:

Loading...

COVID-19, cancer, SARS-CoV-2, decision support tool; CORONET

2.

Avelumab in Combination with Standard of Care Chemoradiotherapy Versus Chemoradiotherapy Alone in Patients with Locally Advanced SCCHN: A Randomised, Double-Blind, Phase 3 Trial

Number of pages: 28 Posted: 09 Sep 2020
Memorial Sloan Kettering Cancer Center - Department of Radiation Oncology, University of Pittsburgh - Hillman Cancer Center, National and Kapodistrian University of Athens - Section of Medical Oncology, Harvard University - Department of Medical Oncology, National Cancer Center Hospital East, Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), NHS Foundation Trust - Royal Marsden Hospital, National Yang Ming University - Taipei Veterans General Hospital, Changhua Christian Hospital - Department of Radiation Oncology, University of Oklahoma - Stephenson Cancer Center, Instituto Português de Oncologia de Coimbra Francisco Gentil, Semmelweis University - Onkológiai Tanszék, Centre Hospitalier Prive Saint Grégoire - CHP Saint Grégoire, Costa del Sol Hospital - Department of Medical Oncology, Fudan University - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, Budgetary Institution of Healthcare of the Omsk Region - Clinical Oncology Dispensary, Pfizer AG, Pfizer, Inc., Pfizer, Inc. and University of California, San Diego (UCSD) - Moores Cancer Center
Downloads 58 (738,188)

Abstract:

Loading...

avelumab, JAVELIN Head and Neck 100, PD-L1, squamous cell carcinoma of the head and neck, immunotherapy, radiation, chemotherapy